Nifedipine
Product Images NDC 43386-440

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 43386-440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2be1748e-figure-01 (2be1748e Figure 01)

FDA Label Image

650b510b 52a3 4d63 E053 2a91aa0a9915

FDA Label Image

Ivc Np 39857 Nifedipine (outser1)

Ivc Np 39857 Nifedipine (outser1)
Nifedipine Capsules is a soft gelatin capsule used for oral administration. It is an antianginal drug belonging to calcium channel blockers that selectively inhibits calcium ion influx across cell membranes of cardiac muscle and vascular smooth muscle without changing serum calcium concentrations. It is used for the management of vasospastic angina and chronic stable angina without evidence of vasospasm. The medication decreases peripheral vascular resistance and carefully monitoring blood pressure is recommended. Adverse effects and drug interactions are also discussed in the description.*
FDA Label Image

Ivc Np 39857 Nifedipine (outser2)

Ivc Np 39857 Nifedipine (outser2)
The text describes the drug Nifedipine and provides information on areas such as dosage and administration, adverse reactions, and drug interactions. The text outlines how the dosage must be established by titration to suppress angina and excessive doses can result in hypotension. The drug interactions stated involve the possible effects of grapefruit juice, co-administration of nifedipine with beta blockers or long-acting nitrates. The text gives a list of side effects and possible effects of Nifedipine when used by pregnant women. The text also describes how nifedipine overdosage is limited, and the drug must be monitored by healthcare professionals. The text is meant to inform and provide guidance to healthcare professionals that prescribe or use Nifedipine.*
FDA Label Image

Label (Nifedine Capsules 2.0001x4.5023)

Label (Nifedine Capsules 2.0001x4.5023)
Each capsule of this medicine contains 10mg of Nifedipine, USP. It is recommended to store between 20-25°C to maintain its efficacy. Nifedipine capsules should be protected from moisture, light, and humidity. Additionally, it should be dispensed only in a tightly closed container. The manufacturer of the medicine is International Vitamin Corporation while it is manufactured for Lupin Pharmaceuticals Inc. The package contains 100 capsules. This text seems to be an insert found in a package.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.